These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1082 related articles for article (PubMed ID: 23534055)
21. NMDA antagonist treatment of depression. Williams NR; Schatzberg AF Curr Opin Neurobiol; 2016 Feb; 36():112-7. PubMed ID: 26687375 [TBL] [Abstract][Full Text] [Related]
22. GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine. Liu RJ; Duman C; Kato T; Hare B; Lopresto D; Bang E; Burgdorf J; Moskal J; Taylor J; Aghajanian G; Duman RS Neuropsychopharmacology; 2017 May; 42(6):1231-1242. PubMed ID: 27634355 [TBL] [Abstract][Full Text] [Related]
23. Ketamine Induces Lasting Antidepressant Effects by Modulating the NMDAR/CaMKII-Mediated Synaptic Plasticity of the Hippocampal Dentate Gyrus in Depressive Stroke Model. Abdoulaye IA; Wu SS; Chibaatar E; Yu DF; Le K; Cao XJ; Guo YJ Neural Plast; 2021; 2021():6635084. PubMed ID: 33981335 [TBL] [Abstract][Full Text] [Related]
24. Ketamine as a novel antidepressant: from synapse to behavior. Murrough JW Clin Pharmacol Ther; 2012 Feb; 91(2):303-9. PubMed ID: 22205190 [TBL] [Abstract][Full Text] [Related]
25. Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms. Krystal JH; Kavalali ET; Monteggia LM Neuropsychopharmacology; 2024 Jan; 49(1):41-50. PubMed ID: 37488280 [TBL] [Abstract][Full Text] [Related]
26. Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect. Bottemanne H; Berkovitch L; Gauld C; Balcerac A; Schmidt L; Mouchabac S; Fossati P Neurosci Biobehav Rev; 2023 Nov; 154():105410. PubMed ID: 37793581 [TBL] [Abstract][Full Text] [Related]
27. Differential Mechanisms Underlying Antidepressant Responses of Ketamine and Imipramine. Wei Z; Zhang K; Zhou Q; Huang M; Xu T; Dong J; Zheng Y; Cai X CNS Neurol Disord Drug Targets; 2017; 16(7):846-853. PubMed ID: 28462695 [TBL] [Abstract][Full Text] [Related]
28. Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression. Sos P; Klirova M; Novak T; Kohutova B; Horacek J; Palenicek T Neuro Endocrinol Lett; 2013; 34(4):287-93. PubMed ID: 23803871 [TBL] [Abstract][Full Text] [Related]
29. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan. Lauterbach EC Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777 [TBL] [Abstract][Full Text] [Related]
30. A synaptic locus for TrkB signaling underlying ketamine rapid antidepressant action. Lin PY; Ma ZZ; Mahgoub M; Kavalali ET; Monteggia LM Cell Rep; 2021 Aug; 36(7):109513. PubMed ID: 34407417 [TBL] [Abstract][Full Text] [Related]
31. Sex Differences in the Temporal Neuromolecular and Synaptogenic Effects of the Rapid-acting Antidepressant Drug Ketamine in the Mouse Brain. Thelen C; Flaherty E; Saurine J; Sens J; Mohamed S; Pitychoutis PM Neuroscience; 2019 Feb; 398():182-192. PubMed ID: 30537521 [TBL] [Abstract][Full Text] [Related]
32. Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy. Widman AJ; McMahon LL Proc Natl Acad Sci U S A; 2018 Mar; 115(13):E3007-E3016. PubMed ID: 29531088 [TBL] [Abstract][Full Text] [Related]
33. Calcium/Calmodulin-Dependent Protein Kinase II and Eukaryotic Elongation Factor 2 Kinase Pathways Mediate the Antidepressant Action of Ketamine. Adaikkan C; Taha E; Barrera I; David O; Rosenblum K Biol Psychiatry; 2018 Jul; 84(1):65-75. PubMed ID: 29395043 [TBL] [Abstract][Full Text] [Related]
34. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review. du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695 [TBL] [Abstract][Full Text] [Related]
35. Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants. Wang YT; Zhang NN; Liu LJ; Jiang H; Hu D; Wang ZZ; Chen NH; Zhang Y Biochem Biophys Res Commun; 2022 Feb; 594():46-56. PubMed ID: 35074585 [TBL] [Abstract][Full Text] [Related]
36. Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant. Kokane SS; Armant RJ; Bolaños-Guzmán CA; Perrotti LI Behav Brain Res; 2020 Apr; 384():112548. PubMed ID: 32061748 [TBL] [Abstract][Full Text] [Related]
37. Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism. Aleksandrova LR; Phillips AG; Wang YT J Psychiatry Neurosci; 2017 Jun; 42(4):222-229. PubMed ID: 28234212 [TBL] [Abstract][Full Text] [Related]
39. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress. Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109 [TBL] [Abstract][Full Text] [Related]
40. Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments. Kadriu B; Musazzi L; Henter ID; Graves M; Popoli M; Zarate CA Int J Neuropsychopharmacol; 2019 Feb; 22(2):119-135. PubMed ID: 30445512 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]